652 related articles for article (PubMed ID: 17970827)
1. Glomerular filtration rate estimates decrease during high altitude expedition but increase with Lake Louise acute mountain sickness scores.
Pichler J; Risch L; Hefti U; Merz TM; Turk AJ; Bloch KE; Maggiorini M; Hess T; Barthelmes D; Schoch OD; Risch G; Huber AR
Acta Physiol (Oxf); 2008 Mar; 192(3):443-50. PubMed ID: 17970827
[TBL] [Abstract][Full Text] [Related]
2. Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m.
Bloch KE; Turk AJ; Maggiorini M; Hess T; Merz T; Bosch MM; Barthelmes D; Hefti U; Pichler J; Senn O; Schoch OD
High Alt Med Biol; 2009; 10(1):25-32. PubMed ID: 19326598
[TBL] [Abstract][Full Text] [Related]
3. Intraocular pressure during a very high altitude climb.
Bosch MM; Barthelmes D; Merz TM; Truffer F; Knecht PB; Petrig B; Bloch KE; Hefti U; Schubiger G; Landau K
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1609-13. PubMed ID: 19875651
[TBL] [Abstract][Full Text] [Related]
4. New insights into changes in corneal thickness in healthy mountaineers during a very-high-altitude climb to Mount Muztagh Ata.
Bosch MM; Barthelmes D; Merz TM; Knecht PB; Truffer F; Bloch KE; Thiel MA; Petrig BL; Turk AJ; Schoch OD; Hefti U; Landau K
Arch Ophthalmol; 2010 Feb; 128(2):184-9. PubMed ID: 20142540
[TBL] [Abstract][Full Text] [Related]
5. MEDEX 2015: Heart Rate Variability Predicts Development of Acute Mountain Sickness.
Sutherland A; Freer J; Evans L; Dolci A; Crotti M; Macdonald JH
High Alt Med Biol; 2017 Sep; 18(3):199-208. PubMed ID: 28418725
[TBL] [Abstract][Full Text] [Related]
6. Nocturnal periodic breathing during acclimatization at very high altitude at Mount Muztagh Ata (7,546 m).
Bloch KE; Latshang TD; Turk AJ; Hess T; Hefti U; Merz TM; Bosch MM; Barthelmes D; Hefti JP; Maggiorini M; Schoch OD
Am J Respir Crit Care Med; 2010 Aug; 182(4):562-8. PubMed ID: 20442435
[TBL] [Abstract][Full Text] [Related]
7. Heart rate variability during two sequential mountaineering expeditions.
Tryliskyy Y
Travel Med Infect Dis; 2011 May; 9(3):165-8. PubMed ID: 21602105
[TBL] [Abstract][Full Text] [Related]
8. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude.
Grissom CK; Richer LD; Elstad MR
Chest; 2005 Feb; 127(2):565-70. PubMed ID: 15705997
[TBL] [Abstract][Full Text] [Related]
9. Regional differences in the cerebral blood flow velocity response to hypobaric hypoxia at high altitudes.
Feddersen B; Neupane P; Thanbichler F; Hadolt I; Sattelmeyer V; Pfefferkorn T; Waanders R; Noachtar S; Ausserer H
J Cereb Blood Flow Metab; 2015 Nov; 35(11):1846-51. PubMed ID: 26082017
[TBL] [Abstract][Full Text] [Related]
10. Oxidative Stress in Acute Hypobaric Hypoxia.
Irarrázaval S; Allard C; Campodónico J; Pérez D; Strobel P; Vásquez L; Urquiaga I; Echeverría G; Leighton F
High Alt Med Biol; 2017 Jun; 18(2):128-134. PubMed ID: 28326844
[TBL] [Abstract][Full Text] [Related]
11. Effects of altitude exposure on brain natriuretic peptide in humans.
Woods D; Hooper T; Hodkinson P; Ball S; Wakeford R; Peaston B; Bairsto C; Green N; Mellor A
Eur J Appl Physiol; 2011 Nov; 111(11):2687-93. PubMed ID: 21394641
[TBL] [Abstract][Full Text] [Related]
12. New insights into ocular blood flow at very high altitudes.
Bosch MM; Merz TM; Barthelmes D; Petrig BL; Truffer F; Bloch KE; Turk A; Maggiorini M; Hess T; Schoch OD; Hefti U; Sutter FK; Pichler J; Huber A; Landau K
J Appl Physiol (1985); 2009 Feb; 106(2):454-60. PubMed ID: 19057000
[TBL] [Abstract][Full Text] [Related]
13. Changes of coagulation parameters during high altitude expedition.
Pichler Hefti J; Risch L; Hefti U; Scharrer I; Risch G; Merz TM; Turk A; Bosch MM; Barthelmess D; Schoch O; Maggiorini M; Huber AR
Swiss Med Wkly; 2010 Feb; 140(7-8):111-7. PubMed ID: 19950043
[TBL] [Abstract][Full Text] [Related]
14. Altitude preexposure recommendations for inducing acclimatization.
Muza SR; Beidleman BA; Fulco CS
High Alt Med Biol; 2010; 11(2):87-92. PubMed ID: 20586592
[TBL] [Abstract][Full Text] [Related]
15. Study of acute mountain sickness during "rapid ascent" trekking to extreme altitude.
Mistry G; Chandrashekhar Y; Sen U; Anand IS
J Assoc Physicians India; 1993 Aug; 41(8):500-2. PubMed ID: 8294352
[TBL] [Abstract][Full Text] [Related]
16. Higher venous bicarbonate concentration associated with hypoxemia, not acute mountain sickness, after ascent to moderate altitude.
Cumbo TA; Braude D; Basnyat B; Rabinowitz L; Lescano AG; Shah MB; Radder DJ; Bashyal G; Gambert SR
J Travel Med; 2005; 12(4):184-9. PubMed ID: 16086892
[TBL] [Abstract][Full Text] [Related]
17. Determinants of acute mountain sickness and success on Mount Aconcagua (6962 m).
Pesce C; Leal C; Pinto H; González G; Maggiorini M; Schneider M; Bärtsch P
High Alt Med Biol; 2005; 6(2):158-66. PubMed ID: 16060850
[TBL] [Abstract][Full Text] [Related]
18. Intermittent altitude exposures reduce acute mountain sickness at 4300 m.
Beidleman BA; Muza SR; Fulco CS; Cymerman A; Ditzler D; Stulz D; Staab JE; Skrinar GS; Lewis SF; Sawka MN
Clin Sci (Lond); 2004 Mar; 106(3):321-8. PubMed ID: 14561214
[TBL] [Abstract][Full Text] [Related]
19. A potential role for free radical-mediated skeletal muscle soreness in the pathophysiology of acute mountain sickness.
Bailey DM; Davies B; Young IS; Hullin DA; Seddon PS
Aviat Space Environ Med; 2001 Jun; 72(6):513-21. PubMed ID: 11396556
[TBL] [Abstract][Full Text] [Related]
20. AltitudeOmics: cerebral autoregulation during ascent, acclimatization, and re-exposure to high altitude and its relation with acute mountain sickness.
Subudhi AW; Fan JL; Evero O; Bourdillon N; Kayser B; Julian CG; Lovering AT; Panerai RB; Roach RC
J Appl Physiol (1985); 2014 Apr; 116(7):724-9. PubMed ID: 24371013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
